Dongwon Securities poaches JP Morgan Chase banker

Dongwon Securities established its OTC derivatives sales team in July following regulatory changes that opened up the country’s OTC derivatives market to securities firms. Currently, the OTC derivatives sales desk consists of a team of eight but an official at the firm said it plans to add more staff in sales and trading. The official added that the firm will offer equity, interest rate and foreign exchange derivatives, but doesn’t expect to begin trading until the second quarter of 2003. At Dongwon, Kim will report directly to the president of the firm, Young Kyu Kim.

An official at the Financial Supervisory Commission, the local regulator, added that Dongwon Securities, Hana Securities, Woori Securities and Goodmorning Shinhan Securities (formerly Good Morning Securities prior to its merger with Shinhan Securities in August) all applied for a licence to trade OTC derivatives at the end of October.

So far, Samsung Securities, Daewoo Securities and LG Investment and Securities have received OTC derivatives licences, receiving regulatory approval in October.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here